Endocannabinoid signaling as a synaptic circuit breaker in neurological disease.
about
The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptorsAutism-associated neuroligin-3 mutations commonly disrupt tonic endocannabinoid signalingβ-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid SignalingAnticancer mechanisms of cannabinoidsPlasticity of Hippocampal Excitatory-Inhibitory Balance: Missing the Synaptic Control in the Epileptic BrainMicroglial Cells as a Link between Cannabinoids and the Immune Hypothesis of Psychiatric DisordersThe stressed synapse: the impact of stress and glucocorticoids on glutamate transmissionMonoacylglycerol lipase - a target for drug development?Modulation of the endocannabinoid system: vulnerability factor and new treatment target for stimulant addictionCannabis and psychosis: NeurobiologyDevelopment of sensory gamma oscillations and cross-frequency coupling from childhood to early adulthoodCannabinoids and Epilepsy.Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage.Excitation-inhibition discoordination in rodent models of mental disorders.Hippocampal sharp wave-ripple: A cognitive biomarker for episodic memory and planningPolymodal activation of the endocannabinoid system in the extended amygdalaInhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addictionIn vitro and in vivo models of Huntington's disease show alterations in the endocannabinoid systemCannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbancesUncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndromeThe CB1 cannabinoid receptor signals striatal neuroprotection via a PI3K/Akt/mTORC1/BDNF pathwaySocial Stress and Psychosis Risk: Common Neurochemical Substrates?Retrograde endocannabinoid signaling reduces GABAergic synaptic transmission to gonadotropin-releasing hormone neurons.Long-term consequences of perinatal fatty acid amino hydrolase inhibition.Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice.The endocannabinoid system in anxiety, fear memory and habituation.Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects.Social isolation and chronic handling alter endocannabinoid signaling and behavioral reactivity to context in adult ratsDistinct functional and anatomical architecture of the endocannabinoid system in the auditory brainstem.Endocannabinoid-dependent homeostatic regulation of inhibitory synapses by miniature excitatory synaptic activities.Pursuing paradoxical proconvulsant prophylaxis for epileptogenesisRole of CB1 cannabinoid receptors on GABAergic neurons in brain agingGenetic rescue of CB1 receptors on medium spiny neurons prevents loss of excitatory striatal synapses but not motor impairment in HD mice.The expression level of CB1 and CB2 receptors determines their efficacy at inducing apoptosis in astrocytomas.Endocannabinoids differentially modulate synaptic plasticity in rat hippocampal CA1 pyramidal neuronsEndogenous cannabinoid signaling at inhibitory interneurons.Minireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55.A restricted population of CB1 cannabinoid receptors with neuroprotective activityAAV vector-mediated overexpression of CB1 cannabinoid receptor in pyramidal neurons of the hippocampus protects against seizure-induced excitoxicity.Localization of the cannabinoid CB1 receptor and the 2-AG synthesizing (DAGLα) and degrading (MAGL, FAAH) enzymes in cells expressing the Ca(2+)-binding proteins calbindin, calretinin, and parvalbumin in the adult rat hippocampus.
P2860
Q24617322-12BA18DC-8DFB-46E6-AC92-9B57BE8C6968Q24621853-33F5BE5E-5938-44D8-916A-E517DCD37FFFQ26269814-EC5526E9-9640-4149-9CDC-BEEF5BCA0ECBQ26750399-1E57D4D9-0D77-4E43-8CFF-E0C0EE3B1422Q26752412-7B1FC692-0EAA-4540-91A3-055FB9B24B17Q26767489-45D53B01-1FB7-4747-A3FB-C36D5FCBE3F0Q26859198-5B32F440-7A43-401B-B915-AB071E67E36EQ26998964-88913DA0-3E94-4D1E-9E21-843FC75ADC71Q27014154-010D3AAF-2F72-42C9-81E1-045044C9FB86Q27024404-160F6769-1945-4658-8323-B22E3E9991FBQ27303073-B873BB18-70BA-4737-9E78-CD1600DA8624Q27336451-FAE7E0F7-677C-4374-891C-BE0361F0DFC3Q27336497-A0763703-248E-4B96-A066-F90CA79070ECQ27692087-8C5D9CCA-372A-4E1C-AFD6-67390D8938D2Q28083958-8FE37BFE-EC03-4D63-AA5B-20C7639917E2Q28252319-9DDF503E-021E-41E6-986B-A5606BE89DF5Q28283718-D7FC2988-5C56-4ECA-99B1-C64BE6C957B9Q28570135-83793F38-C1D7-4D6B-B9C6-76632D0F12FEQ28576747-03CCA275-27ED-438D-8ECE-3293D51C069CQ28585288-6479F5C8-13BD-45FD-B241-BEE3961FA446Q29306901-BE23A4B4-C31E-44FD-A606-FE6001ACC7F7Q30364687-794A0946-D651-48F9-8B25-AE7F316473BCQ30415677-2D696C11-9489-4911-B676-25E552D086ABQ30417555-D2ACE693-2430-4F77-8B2E-604534A09666Q30467190-E74E101F-4860-4467-83BF-E489589F4549Q30471032-4CCB11EF-ACB4-4A94-BA1D-3512A6FEDAD3Q30473707-4C14A6C7-71F8-4688-8B63-7E57AC266475Q30475004-217FFC63-0183-458E-95BE-2BE6D9B9BEB5Q30481732-0A98DAAA-2FDB-475F-89FC-044736997FFAQ30492857-7C9FEDC4-5E23-472B-A1B7-673AE5148B4BQ30495206-3FAFE17C-7C0E-4F20-98EE-FA591896F06CQ30502227-492D24FE-3378-4E35-A255-892B4C1BC6CAQ30588621-A5B31F6A-7A03-4B08-81F1-D88B5F24A732Q33525520-2B713FA1-75D7-40B2-9168-0C99A2B5C65DQ33565499-6595B207-7742-4CCB-9DD2-15AEE12F26D9Q33624983-61D0F527-450E-407D-991D-0D02CE73476FQ33636763-1E7E9DAA-FB54-4E66-ABA6-238C73113A49Q33730578-94DFC8E0-5967-4898-A566-2510B2FB5C13Q33784846-8F573C54-72D2-4407-B675-2F278FA873A0Q33814030-A0233B8C-836F-4030-BC8A-240793CE4192
P2860
Endocannabinoid signaling as a synaptic circuit breaker in neurological disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Endocannabinoid signaling as a synaptic circuit breaker in neurological disease.
@en
Endocannabinoid signaling as a synaptic circuit breaker in neurological disease.
@nl
type
label
Endocannabinoid signaling as a synaptic circuit breaker in neurological disease.
@en
Endocannabinoid signaling as a synaptic circuit breaker in neurological disease.
@nl
prefLabel
Endocannabinoid signaling as a synaptic circuit breaker in neurological disease.
@en
Endocannabinoid signaling as a synaptic circuit breaker in neurological disease.
@nl
P356
P1433
P1476
Endocannabinoid signaling as a synaptic circuit breaker in neurological disease.
@en
P2093
István Katona
Tamás F Freund
P2888
P304
P356
10.1038/NM.F.1869
P407
P577
2008-09-05T00:00:00Z